ObsEva (MEX:OBSN N) OCF Margin %: 40.34% (As of Dec. 2022)


MEX:OBSN N ObsEva SA MEX:OBSN N
18 GF Score
Price MXN1.70
View Full Analysis

What is ObsEva OCF Margin %?

ObsEva MEX:OBSN N 18 OCF Margin % is 40.34% as of Dec. 2022. GuruFocus rates MEX:OBSN N with a GF Score™ of 18/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ObsEva's Cash Flow from Operations for the three months ended in Dec. 2022 was MXN154.4 Mil. ObsEva's Revenue for the three months ended in Dec. 2022 was MXN382.8 Mil. Therefore, ObsEva's OCF Margin % for the quarter that ended in Dec. 2022 was 40.34%.

As of today, ObsEva's current OCF Yield % is 0.00%.

The historical rank and industry rank for ObsEva's OCF Margin % or its related term are showing as below:

MEX:OBSN N' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -123.25

MEX:OBSN N's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs MEX:OBSN N: -123.25

ObsEva OCF Margin % Related Terms

ObsEva OCF Margin % Historical Data

* Premium members only.

The historical data trend for ObsEva's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ObsEva OCF Margin % Chart

ObsEva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -227.13 -117.87

ObsEva Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.09 0.00 0.00 0.00 40.34

MEX:OBSN N vs VRTX, REGN, SGEN: OCF Margin % Comparison

For the Biotechnology subindustry, ObsEva's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ObsEva OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ObsEva's OCF Margin % distribution charts can be found below:

* The bar in red indicates where ObsEva's OCF Margin % falls into.


MEX:OBSN N
18GF Score
ObsEva SA MEX:OBSN N
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ObsEva OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ObsEva's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-451.254/382.843
=-117.87 %

ObsEva's OCF Margin for the quarter that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=154.428/382.843
=40.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 40.34% mean?
ObsEva (MEX:OBSN N) has a OCF Margin % of 40.34% as of Dec. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ObsEva and its competitors.
Is ObsEva's OCF Margin % too high?
ObsEva's current OCF Margin % is 40.34%. Overall, ObsEva has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does ObsEva's OCF Margin % compare to VRTX and REGN?
ObsEva's OCF Margin % of 40.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ObsEva and its competitors. ObsEva's current OCF Margin % is 40.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ObsEva stock overvalued right now?
ObsEva (MEX:OBSN N) has a current OCF Margin % of 40.34%. The current OCF Margin % is 40.34%. ObsEva's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ObsEva (MEX:OBSN N), the current OCF Margin % is 40.34% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ObsEva Business Description

Address Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
18GF Score

Get the complete analysis for MEX:OBSN N

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1.70
Price